CD8A and diabetes mellitus: In addition, ZnT8-derived peptides have been identified as important biomarkers of diabetes autoantigens that may trigger a self-reactive CD8+ T lymphocytes response, suggesting that this antigen plays an important role in the progression of the disease [23].